Kabiven Peripheral

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin, the active ingredient in Kabiven Peripheral, is a parenteral nutrition presented as an intravenous solution for intravenous use. It provides essential amino acids to support protein synthesis and nitrogen balance in patients who cannot receive enteral feeding. GNH USA supplies Kabiven Peripheral as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and clinics worldwide.

Kabiven Peripheral is used in parenteral nutrition to support patients who cannot receive enteral feeding. - Postoperative patients: supports protein synthesis and nitrogen balance during recovery. - Critically ill patients: provides essential amino acids when oral intake is not possible. - Trauma patients: helps maintain nutritional status during acute injury.

Kabiven Peripheral may be associated with several adverse reactions.

Common Side Effects: - Hyperglycemia: elevated blood glucose levels during infusion. - Electrolyte imbalance: alterations in serum potassium, sodium or calcium. - Infusion site reactions: redness, swelling or pain at the catheter site. - Fever: transient rise in body temperature.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical attention. - Metabolic acidosis: significant drop in blood pH. - Renal dysfunction: impaired kidney function in susceptible patients.

When using Kabiven Peripheral, clinicians should observe several safety measures. - Renal impairment: monitor renal function and adjust infusion rate. - Liver disease: evaluate hepatic function before initiating therapy. - Electrolyte disorders: correct existing imbalances prior to infusion. - Hyperglycemia risk: regularly check blood glucose levels. - Infection risk: maintain strict aseptic technique during catheter handling. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kabiven Peripheral can interact with other intravenous therapies and systemic medications.

Major Interactions (Avoid): - Concurrent high‑dose potassium solutions: may cause dangerous hyperkalemia. - Incompatible IV drugs (e.g., calcium chloride): risk of precipitation and catheter blockage.

Moderate Interactions (Monitor Closely): - Insulin therapy: glucose levels may fluctuate, requiring dose adjustment. - Diuretics: monitor electrolyte balance closely. - Renal replacement therapy: may necessitate dosing modifications.